Ad
related to: latest news about pfizerpfizerclinicaltrials.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
On the cost side, Pfizer achieved $4 billion in savings and announced an additional $1.5 billion in margin improvements. In R&D, leadership changed for the first time in 15 years,
Pfizer decided to terminate the global collaboration and license agreement between the parties. Sangamo intends to explore all options to advance the program, including seeking a potential new colla
The Seagen deal, as well as its $4 billion cost-cutting plan, are a key part of Pfizer's post-COVID growth stra Pfizer lifts profit forecast as CEO sees reason for optimism in 2024 Skip to main ...
(Reuters) -Pfizer said on Tuesday it expects to close its $43 billion deal to buy cancer drugmaker Seagen later this week and plans to create a new oncology division that includes the acquisition ...
(Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil ...
The company on Wednesday forecast revenue from its COVID-19 vaccine and treatment to be $8 billion in 2024, a far cry from the $57 billion in 2022. In March, Pfizer announced a $43 billion ...
(Reuters) -Pfizer reported a surprise quarterly profit on Tuesday, helped by cost cuts and higher-than-expected demand for its COVID treatment Paxlovid, but sales of some high profile products ...
BioNTech shares dropped 7.2% in Frankfurt trading while Moderna was down 5% and shares of Novavax, whose new shot is only approved in the U.S., were off 7% in New York. Pfizer's COVID outlook cuts ...